Viewing Study NCT06566950



Ignite Creation Date: 2024-10-26 @ 3:38 PM
Last Modification Date: 2024-10-26 @ 3:38 PM
Study NCT ID: NCT06566950
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-08-18

Brief Title: BFR Training on Muscle Morphology
Sponsor: None
Organization: None

Study Overview

Official Title: Effectiveness of Blood Flow Restriction Training on Muscle Morphology and Prevention of Patellofemoral Pain Syndrome and Anterior Cruciate Ligament Injury
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This randomized clinical trial study compares high-load eccentric training HL-Et sham LL-BFRt and low-load blood flow restriction LL-BFRt in sportsmen The primary inquiries it seeks to address are

Is LL-BFR superior to HL-Et and sham LL-BFRt in terms of improving muscle morphology Is LL-BFR a more effective Patellofemoral Pain Syndrome and ACL injury preventive than HL-Et and sham LL-BFRt

The three intervention groups that will be randomly assigned to participants are LL-BFRt sham LL-BFRt and HL-Et Participants are expected to carry out

Participants in LL-BFRt will be required to perform LL eccentric training at 30 of their repetition maximum RM and 70 of their artery occlusion pressure AOP This training will include stairs single leg squat and single leg deadlift

Participants in HL-Et will be required to perform LL eccentric training at 70 of their maximum number of repetitions RM

In order to determine whether muscular morphology and the prevention of Patellofemoral Pain Syndrome and ACL injury improve following the interventions and follow-up researchers will compare LL-BFRt sham LL-BFRt and HL-Et
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None